Optimization of human mesenchymal stem cell isolation from synovial membrane: Implications for subsequent tissue engineering effectiveness  by Sugita, Norihiko et al.
lable at ScienceDirect
Regenerative Therapy 5 (2016) 79e85Contents lists avaiRegenerative Therapy
journal homepage: http: / /www.elsevier .com/locate/rethOriginal ArticleOptimization of human mesenchymal stem cell isolation from
synovial membrane: Implications for subsequent tissue engineering
effectiveness
Norihiko Sugita a, Yu Moriguchi a, Morito Sakaue a, David A. Hart b, Yukihiko Yasui a,
Kota Koizumi a, Ryota Chijimatsu a, Syoichi Shimomura a, Yasutoshi Ikeda a,
Hideki Yoshikawa a, Norimasa Nakamura a, *
a Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita 565-0871, Japan
b McCaig Institute for Bone & Joint Health, University of Calgary, 3330 Hospital Drive Northwest, Calgary, Alberta T2N 4N1, Canadaa r t i c l e i n f o
Article history:
Received 6 July 2016
Received in revised form
19 August 2016





Cell differentiation* Corresponding author.
E-mail address: norimasa.nakamura@ohsu.ac.jp (N
Peer review under responsibility of the Japane
Medicine.
http://dx.doi.org/10.1016/j.reth.2016.09.002
2352-3204/© 2016, The Japanese Society for Regener
(http://creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
Synovium-derived mesenchymal stem cells (SDMSCs) are one of the most suitable sources for cartilage
repair because of their chondrogenic and proliferative capacity. However, the isolation methods for
SDMSCs have not been extensively characterized. Thus, our aim in this study was to optimize the pro-
cesses of enzymatic isolation followed by culture expansion in order to increase the number of SDMSCs
obtained from the original tissue. Human synovium obtained from 18 donors (1.5 g/donor) was divided
into three aliquots. The samples were minced and subjected to collagenase digestion, followed by
different procedures: Group 1, Tissue fragments were removed by ﬁltering followed by removing ﬂoating
tissue; Group 2, No ﬁltering. Only ﬂoating fragments were removed; Group 3, No fragments were
removed. Subsequently, each aliquot was sub-divided into two density subgroups with half. In Group 1,
the cell-containing media was plated either at high (5000 cells/cm2) or low density (1000 cells/cm2). In
Groups 2 and 3, the media containing cells and tissue was plated onto the same number of culture dishes
as used in Group 1, either at high or low density. At every passage, the cells plated at high density were
consistently re-plated at high and those plated at low density were likewise. The expanded cell yields at
day 21 following cell isolation were calculated. These cell populations were then evaluated for their
osteogenic, adipogenic, and chondrogenic differentiation capabilities. The ﬁnal cell yields per 0.25 g
tissue in Group 1 were similar at high and low density, while those in Groups 2 and 3 exhibited higher
when cultured at low density. The cell yields at low density were 0.7 ± 1.2  107 in Group 1,
5.7 ± 1.1  107 in Group 2, 4.3 ± 1.2  107 in Group 3 (Group 1 vs Groups 2 and 3, p < 0.05). In addition,
the cells obtained in each low density subgroup exhibited equivalent osteogenic, adipogenic, and
chondrogenic differentiation. Thus, it was evident that ﬁltering leads to a loss of cells and does not affect
the differentiation capacities. In conclusion, exclusion of a ﬁltering procedure could contribute to obtain
higher number of SDMSCs from synovial membrane without losing differentiation capacities.
© 2016, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Mesenchymal stem cells (MSCs) can be isolated from various
tissues and have the potential to self-renew and differentiate into. Nakamura).
se Society for Regenerative
ative Medicine. Production and homultiple lineages such as osteogenic [1], chondrogenic [2], adipo-
genic [3,4], myogenic [5] and neurogenic [6] speciﬁcities. Among the
MSC sources, synovium-derived mesenchymal stem cells (SDMSCs)
have been demonstrated to exhibit superior chondrogenic and
proliferation potentials compared to MSCs derived from other tissue
[7e9]. A considerable number of studies of cartilage repair have
been conducted using SDMSCs with promising results [10e13]. For
successful cell-based therapy, securing a sufﬁcient number of cells is
critical. It depends on the delivery method, speciﬁc to our “scaffold-sting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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1.3 108 cells for treatment cartilage defect and quality inspection in
our clinical trial (UMIN000008266), [15]. However, optimized
methods for culturing SDMSCs, including the isolation from synovial
membranes have not been fully characterized. Most of the previous
studies on the culture of SDMSCs reported the isolation of cells using
a standard collagenase digestion followed by ﬁltering to remove
debris [7e13,16e23] before starting the primary culture. However,
there may be a potential loss of additional MSCs in the ﬁlter-trapped
undigested tissue fragments. We hypothesized that the use of un-
digested tissue fragments would lead to increases in the number of
SDMSCs available from the original synovial tissue. Moreover, it was
previously reported that plating density can inﬂuence the prolifer-
ation of MSCs [8,24]. Taken together, it was important to quantify
how the ﬁltering process, as well as the plating density of cells
thereafter could affect the number of SDMSCs obtained within a
clinically relevant duration of cell culture.
In the present study we aimed to maximize the yield of cultured
human SDMSCs starting from equivalent weights of synovial
membrane material. The results presented indicate that both the
MSC isolation method, as well as the propagation density, signiﬁ-
cantly inﬂuences the assessed outcomes.2. Materials and methods
2.1. Harvest of synovial membrane and isolation of cells
Our study protocol was approved by the institutional committee
for medical ethics. Written informed consent was obtained from all
patients. Human synovial membranes were obtained (1.5 g per
patient) from 18 patients (10 male and 8 female donors; mean age,
25.5; range 16e48 years: Table 1) during arthroscopic surgery.
Synovial tissues from each donor were divided into three aliquots
(0.5 g each) and meticulously minced using surgical scissors. The
minced tissues were then digested in a collagenase solution [440 u/
ml collagenase A, Type AFA (Worthington Biochemical Corporation,
Lakewood, NJ, USA)] in growth medium containing high-glucose
Dulbecco's Modiﬁed Eagle Medium (DMEM, Wako Chemical
Corp., Osaka, Japan), supplemented with 10% fetal bovine serum
(FBS, SigmaeAldrich, St. Louis, MO, USA) and 1% anti-
bioticeantimycotic solution (SigmaeAldrich) according to the
previously established protocol [12,16,25]. Speciﬁcally, we used the
same, animal origin free, collagenase at the same concentration as
we used in our clinical trial (UMIN000008266) according to theTable 1
Synovial samples used in this study.


















18 48 Femalemanufacturer's instruction. Following 3 or 16 h of incubation, un-
digested tissues were removed from the cell-containing liquid with
a 70-mm nylon ﬁlter (BD Falcon, Franklin Lakes, NJ, USA) followed
by centrifugation (1500 rpm for 5 min). Subsequently, the ﬂoating
undigested tissue fragments were removed (Group 1). In Group 2,
No ﬁltering was performed but ﬂoating undigested tissue frag-
ments were removed after centrifugation. In Group 3, No ﬁltering
and the ﬂoating undigested tissue fragments were not removed,
and all components used for the subsequent cell culture. Therefore,
Group 1 contained only cells; Group 2 contained cells and the
precipitated undigested tissue fragments; while Group 3 contained
cells plus both the precipitated and ﬂoating undigested tissue
fragments (Fig. 1). In each group, all the contents were re-
suspended in 10 ml of complete media.
For microscopic observation, cell-containing media (10 ml) from
Groups 1e3 were applied onto cell counter plates for analysis.
DNAwas extracted from the cell-containing liquid (100 ml) after
collagenase digestion in all groups with a DNeasy Blood & Tissue
Kit (QIAGEN, Tokyo, Japan) according to the manufacturer's in-
structions. Brieﬂy, cells and small tissues were digested with lysis
buffer and proteinase K, DNA was puriﬁed, and the DNA content
was quantiﬁed in a spectrophotometer. Total DNA content per 0.5 g
tissue was calculated according to the ratio of sampling volume
(100 ml) to the total volume (10 ml) of the cell-containing
suspension.
2.2. Plating and subsequent primary cell culture
Each aliquot (Groups 1e3) from individual donors was further
divided into two subgroups (5 ml each) for subsequent plating at
two different cell densities.
For Group 1, the cells were plated at high (5000 cells/cm2) or
low density (1000 cells/cm2). For Groups 2 and 3, media containing
cells and undigested tissues was plated onto the same number of
culture dishes used in Group 1, either at high or low density. Cells
were cultured in the growthmedium containing 10% FBS at 37 C in
a humidiﬁed atmosphere of 95% air and 5% CO2. The medium was
replaced every 4 days.
2.3. In vitro expansion of cell populations
The cultured cells were subjected to passaging when reaching
80% conﬂuency. Cells were harvested by treatment with tryp-
sineEDTA (0.25% trypsin and 1 mM EDTA; Gibco BRL, LifeDiagnosis
Anterior cruciate ligament injury
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Anterior cruciate ligament injury
Anterior cruciate ligament injury
Anterior cruciate ligament injury
Osteochondromatosis
Anterior cruciate ligament injury
Anterior cruciate ligament injury
Anterior cruciate ligament injury
Anterior cruciate ligament injury
Anterior cruciate ligament injury
Anterior cruciate ligament injury
Meniscal injury
Anterior cruciate ligament injury
Meniscal injury
Anterior cruciate ligament injury
Fig. 1. Traditional process of enzymatic cell isolation from synovial membrane and
grouping. ① Human synovial membranes were obtained from arthroscopic surgeries
and divided into 3 groups (0.5 g for each group). ② The tissues were meticulously
minced.③ The fragments were digested in collagenase solution.④ After 3 h digestion,
Group 1 (Conventional method): precipitated tissues were removed by ﬁltering fol-
lowed by the removal of ﬂoating tissues after centrifugation; Group 2 No ﬁltering. Only
ﬂoating tissues were removed after centrifugation; Group 3: No ﬁltering. No removal
of ﬂoating tissue.⑤ In Group 1, Nucleated cells are counted and plated in the dishes at
high and low densities. In Groups 2 and 3, the media containing cells and undigested
tissues was plated onto the same number of culture dishes used in Group 1.
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cells plated at high density were consistently re-plated at high
density (5000 cells/cm2) and those plated at low density were
likewise re-plated at low density (1000 cells/cm2) thereafter.
In our on-going clinical trial protocol (UMIN000001195), the
duration for the expansion of SDMSCs was set at approximately 3
weeks [26], similar to another clinical trial using bone marrow
derived MSCs [27]. Thus, we chose to set the duration for cell
expansion at a clinically relevant 21 days, and the ﬁnal cell number
per 0.25 g tissue in each subgroup was calculated for comparison to
assess optimal in vitro conditions.
2.4. In vitro differentiation protocols
Cells obtained after 21 days of culture for each low density
subgroup were used for lineage-speciﬁc differentiation assays.
2.4.1. Osteogenic differentiation
2  104 cells in each subgroup were plated in 12-well plates and
then cultured in complete medium for 2 days. The medium was
then changed to osteogenesis medium (STEMPRO® Osteogenesis
Differentiation Kit, Life Technologies, Grand Island, NY, USA) and
cultured for another 21 days. The medium was replaced two times
per week. After induction for 21 days, the wells were washed twotimes with PBS, ﬁxed in 4% paraformaldehyde, and then stained
with 0.5% Alizarin Red S.
2.4.2. Adipogenic differentiation
2  104 cells were plated in 12-well plates and cultured in
complete medium for 2 days. The medium was then changed to
adipogenesis medium (STEMPRO® Adipogenesis Differentiation Kit,
Life Technologies) and cultured for another 7 days. The medium
was replaced two times a week. After induction for 7 days, wells
were washed two times with PBS and stained with Oil Red O.
2.4.3. Chondrogenic differentiation
2  105 cells were placed in 15 ml polypropylene tubes and
centrifuged at 1500 rpm for 10 min. The cell pellets were cultured in
complete medium for 2 days. The medium was then switched to
chondrogenic medium, comprised of DMEM supplemented with 1%
insulinetransferrineselenium supplement (Corning® ITS Premix,
Corning Life Sciences, Bedford, MA, USA), 0.2 mM Asc-2P (Sigma-
eAldrich), and200ng/mL recombinanthumanBMP2 (OsteoPharma,
Osaka, Japan) for another 21 days. The medium was replaced two
times per week. For histological analysis, two pellets were ﬁxedwith
4% paraformaldehyde, embedded in parafﬁn, cut into 5-mm sections,
and stained with Safranin O. Nuclei were counterstained with he-
matoxylin. For quantifying the glycosaminoglycan (GAG) content,
three pellets were digested with 0.4 M papain extraction reagent
overnight at 65 C, and the GAG content was measured by Blyscan
sulfated GAG assay kit (Biocolor, Carrickfergus, Ireland).
2.5. Statistical analysis
Data was presented as the mean ± one standard error of the
mean. Data input and calculations were performed with IBM SPSS
Statistics 22 (IBM, Armonk, NY, USA). In all analyses, we used a
linear mixed model. We included the combination of groups and
densities as a ﬁxed effect and a repeated effect. A value of p < 0.05
was considered statistically signiﬁcant.
3. Results
3.1. The effect of ﬁltering following collagenase digestion
In Group 1, cell density appeared to be lower than in Groups 2
and 3, in which more cells along with cell aggregates and undi-
gested tissues were observed (Fig. 2a). The total DNA content was
3.9 ± 7.2 mg in Group 1, 42.0 ± 7.2 mg in Group 2, 42.3 ± 10.0 mg in
Group 3. Therewere signiﬁcant differences between Groups 1 and 2
(p < 0.01) and between Groups 1 and 3 (p < 0.05). The differences
for each comparison were approximately 10 fold. No signiﬁcant
differences between Groups 2 and 3 were detected (Fig. 2b).
Extending the initial collagenase digestion time to 16 h did not
lead to any signiﬁcant increases in cell numbers for Group 1 (data
not shown) and therefore, it was likely that the cells populated
within the undigested tissues were not released even by longer
exposure to collagenase.
3.2. Comparison of cell numbers obtained after 21-day culturing of
each sub-group
The cell number after 21 days of culture per 0.25 g tissue was
calculated for each subgroup. There were no signiﬁcant differences
between the high and low density subgroups (0.6 ± 0.9  107 cells
vs 0.7 ± 1.2  107 cells) in Group 1, whereas more cells were ob-
tained for the low density subgroups than the high density sub-
groups for Groups 2 (5.7 ± 1.1 107 cells vs 3.1 ± 1.07 cells, p < 0.05)
and 3 (4.4 ± 1.2  107 cells vs 1.5 ± 1.5  107 cells, p < 0.05) (Fig. 3).
Fig. 2. Evaluation of the ﬁlter processing effect on cell-containing ﬂuids. (a) The cell-containing liquids (10 ml) were applied onto cell counter plates (digested liquid from 0.5 g
tissue/10 ml) in each group. 1 Grid ¼ 0.25 mm. (b) The DNA content in the cell-containing liquids from 0.5 g tissue in each group. *p < 0.05, **p < 0.01.
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signiﬁcantly greater than the values for Group 1 (Group 2 vs 1, >8-
fold; p < 0.01, Group 3 vs 1, >6-fold; p < 0.05). The cell viability was
over 90% after all the different protocols (data was not shown).
3.3. In vitro differentiation and histological analyses of cells
Since cell expansion in the low density culture subgroups
showed enhanced results compared to the ﬁndings obtained at
high density for all of the groups (1, 2 and 3), we focused on
comparing the differentiation capacity of the expanded cells only
among the lower density culture subgroups.
3.3.1. Osteogenesis
After 21 days of osteogenic induction, mineralization was
similarly observed for all groups, with calcium deposition stained
with Alizarin Red S (Fig. 4a).
3.3.2. Adipogenesis
Following 7 days of adipogenic induction, under light micro-
scopy, Oil Red O-stained sections revealed similar formation of lipid
vacuoles for cells of each group (Fig. 4b).
3.3.3. Chondrogenesis
After 21 days of chondrogenic induction, the cell pellets cultured
in chondrogenic media showed intense staining for Safranin O in
each group (Fig. 5b). Regarding GAG quantity, there was no signif-
icant statistical difference among the three groups (1, 2, 3) (Fig. 5c).4. Discussion
In most of the previous studies used for the preparation of
SDMSCs, a ﬁltering process was included following collagenase
digestion to remove undigested tissue fragments [7e13,16e23].
The present study has revealed that such ﬁltering procedures result
in a signiﬁcant loss (approximately 90% by DNA content measure-
ment) of the number of the cells obtained when compared with
cultures not subjected to ﬁltering. It was likely that not all of the
cells contained in the collagenase-treated media adhered to the
culture dish and participate in subsequent proliferation. Therefore,
loss of 90% of cells by the comparison of DNA content may be an
overestimation. However, it is reasonable to presume that the
majority of the SDMSCs are still within the undigested tissues after
collagenase digestion for 3 or 16 h.
Final cell yields after 21 days of culture in the non-ﬁltered
groups (i.e. Group 2 and 3) were higher than those of the ﬁltered
group (i.e., Group 1). As previously reported [8,24], the proliferative
efﬁciency was higher at low density culture than at high density for
the non-ﬁltered groups (Group 2 and 3), and the ﬁnal cell yield in
Group 2 (low density culture subgroup) which exhibited the best
yields in the non-ﬁltered groups yielded 5-fold more cells than
those in Group 1. Conversely, such differences based on culture cell
density were not detected for the ﬁltered group (Group 1). All these
results very clearly indicate the negative effect of the ﬁltering
process.
The differences between Groups 2 and 3 were based onwhether
the ﬂoating undigested tissue fragments separated after centrifu-
gation were utilized for the subsequent culture. Microscopic
Fig. 3. Comparison of cell numbers from Groups 1e3 obtained after in vitro culturing for 21 days. Cell number calculated after 21 days for cells cultured at high density (H) and low
density (L). *p < 0.05, **p < 0.01.
Fig. 4. Osteogenic and adipogenic differentiation capacity for cells in Groups 1e3. (a) Osteogenic differentiation: 21-day expanded cells cultured at low density replated in 12-well
plates and osteogenesis induced for another 21 days for each group. Resultant cultures were then stained with Alizarin Red S. (b) Adipogenic differentiation: 21-days expanded cells
at low density were then subjected to adipogenesis for another 7 days and were subsequently stained with Oil Red O. Scale bars ¼ 100 mm.
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are comprised mainly of adipose synovium, a ﬁnding consistent
with the ﬂoating properties of the fragments, and whose strong
chondrogenic differentiation capacity has been reported previously
[28,29]. Based on these reports, we assessed whether retention of
such ﬂoating tissue fragments plus the precipitated undigested
tissue fragments at the subsequent culture stage would be bene-
ﬁcial on subsequent culture to obtaining better yields of SDMSCs.
However, the results showed no such signiﬁcant differences be-
tween Groups 2 and 3. It could be speculated that the ﬂoatingundigested tissue fragments may not have become well adhered to
the culture dish and thus, might have missed the opportunity for
outgrowth of the SDMSCs. The preparation method for Group 2 is
simpler than that for Group 3 because there is no need to carefully
preserve the ﬂoating tissue fragments at the collagenase washing
out process. Thus, both in terms of efﬁciency of cell expansion and
simplicity in preparation method, we recommend the Group 2
method for the isolation of SDMSCs.
There was a possibility that isolating methods affect cell dif-
ferentiation capacity, however three groups showed similar stain in
Fig. 5. Chondrogenic differentiation potential for cells from Groups 1e3. 21-days expanded cells at low density were pelleted by centrifugation and chondrogenesis subsequently
induced for another 21 days. (a) Cell pellets in each group were measured against a 1-mm scale bar. (b) Histological appearance with Safranin O. Scale bars ¼ 100 mm. (c) GAG
content per cell pellet. The data for the uninduced control groups in relation to GAG content is shown as the mean for all three groups. *p < 0.05.
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niﬁcant statistical difference among the three groups in GAG
quantify. So we conclude that the cells in non-ﬁlter groups have
equivalent differentiation capacities to those in ﬁlter group.
As another method of cell isolation from tissues, explant culture
has been initially reported as adipose tissues [30], Wharton's jelly
[31], and synovium [23]. In all these papers, explant culture was
compared with an enzymatic method employing ﬁltering; in the
report about synovial tissues, the cell yield from explant culture
was reported to be equal to that from the enzymatic method.
Conversely, in the present study, cell yield from the enzymatic
method without ﬁltering was superior to that with ﬁltering, and
the cell differentiation capacity was not affected by the use of
ﬁltering or not. Although we did not directly compare our methods
tested with explant culture, these ﬁnding suggest that the enzy-
matic method without ﬁltering (enzymatic explant method) pro-
vides more cells than explant culture. The enzymatic digestion of
collagenous matrix might have facilitated cellular expansion out of
the matrix as compared with traditional explant culture.
One issue which still remains unclear was whether the MSCs
readily released from the synovial membrane tissue by the colla-
genase treatment represent a unique subpopulation when
compared to those that are retained in the undigested tissue frag-
ments. As the number of cells released from the synovial mem-
brane tissue was not increased when the collagenase treatment
was extended to 16 h (data not shown), the digestion time more
than 3 h was not a limiting factor and the cells released appeared to
be a subset of the total cells available.
As a potential concern, the use of serum in our collagenase-
based digestion media might have reduced the action of collage-
nase, leading to the presence of undigested tissue debris after
digestion process. We included serum according to the protocols
previously published [12,16,25], and did not investigate the ex-
periments with serum-free digestion media. In the literature, there
have been several reports of synovial digestion by collagenase
without the use of serum [7,19,32]. In these studies, the duration of
digestionwas 3 h to overnight, and notably, all the reports included
ﬁltering process after collagenase digestion. This suggests the
presence of residual debris (undigested tissue) after collagenase
digestion regardless of the presence of serum. Thus, the presence of
serum or not in the collagenase solution does not likely affect the
major conclusion of the present study.
Recent study reported that more primitive progenitors are
included in non-adherent cells [33,34], so there may be potential
improvement of the quantity and quality of stem cell population ifwe follow the procedures. In the present study, we discarded me-
dium that could potentially contain non-adherent cells at the time
of medium change and passage and thus could not conﬁrm the
improvement. This issue needs to be clariﬁed in the future study.
Some other limitations of the present study include its relatively
small sample size, no comparison of gender, and individual differ-
ences. More donor samples are need to be assessed to further
clarify these issues, as well as perhaps inclusion of clonal, genetic,
and epigenetic analysis of the different cell populations.
5. Conclusions
We have developed a simpler and signiﬁcantly more efﬁcient
method for SDMSCs isolation than the conventional isolation
method which employs a ﬁltering process. Without the use of any
special equipment such as a bioreactor or the addition of biological
reagents or growth factors, we succeeded in increasing the cell
yield over 5-fold, a ﬁnding which is very relevant when considering
future clinical applications to repair cartilage defects. In addition,
this methodology may be applicable to MSC isolation from other
tissue cell sources, but future research to examine the feasibility of
applying this method to other MSC sources will be required.
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